NorthWest Biotherapeutics Inc (NWBO)

[Jack2479]

Well what’s the full cost of a phase three double blinded placebo controlled trial....over 10 years? There is a reason why tiny little biotechs rarely succeed...the odds are stacked against them and are obviously easy pickings for any kind of stock play. We are lucky that the intellectual property is all owned by NWBO. Cognate will do well and they should as without them the story is likely to have an unhappy ending for shareholders in NWBO.....we are chasing down the last few yards of a marathon journey and NWBO have all but delivered a completed phase three trial while remaining independent and with no income.....so it’s fingers crossed for very good topline data. Long suffering longs should get a great return on their hard-earned money that went into building a gold standard phase three clinical trial. I’m sure you will join me in wanting a successful conclusion for the benefit of patients, shareholders and stakeholders alike.